Oppenheimer Reaffirms Their Hold Rating on HEXO (HEXO)
In a report released today, Rupesh Parikh from Oppenheimer maintained a Hold rating on HEXO (HEXO). The company’s shares closed last Monday at $0.77, close to its 52-week low of $0.62.
According to TipRanks.com, Parikh is a 5-star analyst with an average return of 13.1% and a 58.6% success rate. Parikh covers the Services sector, focusing on stocks such as United Natural Foods, Sprouts Farmers, and Dollar General.
The word on The Street in general, suggests a Hold analyst consensus rating for HEXO with a $1.39 average price target, which is a 98.6% upside from current levels. In a report released yesterday, MKM Partners also maintained a Hold rating on the stock with a C$1.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $8.40 and a one-year low of $0.62. Currently, HEXO has an average volume of 5.34M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.
Read More on HEXO: